Anthropic Weighs Raising IPO Price to $85 a Share After Order Book Closes
Key Facts
Anthropic is considering pricing its initial public offering at around $80 to $85 a share, HotSheet reported, citing Bloomberg, on Nov. 18, 2026. That level would put the price under consideration above the estimated range in the company’s prospectus of $70 to $78 a share. People familiar with the matter said the final price is still being determined, meaning the reported range is not an announced offering price. This comes after the order book closed on Tuesday, Nov. 17, according to a CNBC report carried by Unbiased Headlines. CNBC had noted that after the close, discussions shifted from the possibility of exceeding the initial range to the size of any potential increase.
Anthropic’s prospectus says the $70 to $78 range is its current estimate of the IPO price per share, not the final price. The $80 to $85 range was reported by Bloomberg as a price the company is considering, with the final decision still unresolved. The difference between the two ranges shows the scale of the potential revision under discussion ahead of pricing, but does not establish that the company has adopted a higher price. The order book’s closure on Nov. 17 also means any subsequent change to the price or size of the offering would come after investors submitted their orders, according to CNBC. This information provides neither a final price nor a completed pricing outcome.
In an earlier Reuters report on the roadshow, the IPO order book had reached six times the shares available by the end of Thursday, according to a person cited by the news agency. That information relates to the timing of the earlier report and does not describe demand on Nov. 18 or in itself confirm that the price will rise. It provides context on interest ahead of the book’s close, as the company was considering a price range above the estimate in the prospectus. The distinction between previously reported demand and the price under consideration remains important to understanding what is known about the deal at this stage. The figure reported by Bloomberg remains a range under consideration, not a final IPO outcome.
The prospectus estimates the base offering at 825 million shares, with underwriters given an option to purchase up to 123.75 million additional shares from the company. This amount sets the number of shares in the public offering according to the prospectus estimate, while the additional share option remains separate from the base amount. At the same time, seven companies have agreed, according to the prospectus, to buy Class N shares for a total of $26 billion in a private placement concurrent with the completion of the public offering. The price of those shares is set at the IPO price, according to the document. The private placement’s execution is therefore tied to the price adopted for the public offering, while the figures in the prospectus remain estimates and disclosed deal arrangements.
Anthropic expects to allocate up to 20% of the Class A shares in the offering to retail investors, according to an Associated Press report. That remains an expected allocation cap, not confirmation that the full percentage will go to individual investors. On operating performance, the company recorded revenue of $33.24 billion and an operating loss of $1.26 billion during the first nine months of the year. In the same period of 2025, its operating loss was $5.22 billion, while revenue was less than $2.55 billion, the news agency reported. The comparison puts revenue growth and a narrowing operating loss in the context of the offering, without by itself determining the price to be adopted or the company’s valuation at listing.
Anthropic has applied to list its Class A shares on the Nasdaq Global Select Market under the symbol ANT, according to the prospectus. The document says filing the application does not guarantee an active trading market for the shares. The Associated Press said in a report published on Nov. 18 that trading was expected to begin on Thursday, Nov. 19, 2026, under the schedule announced at the time. That remains an expected date as of the report’s publication, while the share price depends on the final pricing decision. The next step is therefore to determine the price at which the shares will be sold, followed by the start of trading according to the announced schedule.